Day: June 26, 2024

Press release – Neuilly-sur-Seine, Wednesday, June 26, 2024 – 5.45 pm ARGAN launched an urban logistics site in Montpellier End of May, ARGAN was delivered a new logistics site of 4,300 sq.m in the municipality of Castries, located a few kilometres at the North of Montpellier. This new site is operated by a leading player of the mass retail distribution as part of a lease for a fixed-term of 6 years. This site is more particularly dedicated to the e-commerce business and to the home delivery to individual customers all over the metropolitan area of Montpellier, comprising more than 500,000 inhabitants. Located along the A9 French highway, which links Béziers to Nîmes, the Castries site grants delivery access to the heart of Montpellier in 15 minutes and to the rest of the cities part of this metropolitan area in less than an hour. The...

Correction to the press release ‘Bekaert to implement liquidity agreement with Kepler Cheuvreux’ of 25 June 2024 Average closing share price has been corrected. Bekaert announces that it has entered today into a liquidity agreement with Kepler Cheuvreux in relation to its ordinary shares admitted to trading on Euronext Brussels (ISIN Code BE0974258874). This liquidity agreement provides for the purchase and sale of Bekaert shares by Kepler Cheuvreux on the regulated market of Euronext Brussels and with the purpose of supporting the liquidity of the Bekaert shares. Kepler Cheuvreux will be acting on behalf of Bekaert and on a discretionary basis, as authorized by the Extraordinary General Meeting of Bekaert of 13 May 2020. The liquidity program will start on 1 July 2024 for a 12-month renewable period. To execute the liquidity agreement,...

Saint-Herblain (France), June 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Board of Directors were approved by the shareholders at its Combined General Meeting (CGM) held today in Lyon, France. Among the adopted resolutions were approval of the 2023 financial statements, delegations for the management board to increase Valneva’s share capital and/or issue financial instruments, and the appointment of a new director to its Board. Ms. Danièle Guyot-Caparros was appointed to Valneva’s Board of Directors for a three-year term. Ms. Guyot-Caparros has a proven track record in finance and business operations. She started her career in Audit and Corporate Finance with PWC specializing in the Chemical/Pharma Industry. In 1992, she joined Rhône-Poulenc-Rorer...

                Press Release Agreement with Sanofi on a 200 M€ investment through a Perpetual Subordinated Hybrid Bond, upon the completion of the ongoing discussions to amend and extend the current Revolving Credit Facility 75 to 80 M€ annual run-rate incremental Core EBITDA targeted by the end of 2027, driven by the end of higher value API and CDMO offering, a streamlined industrial footprint, and significant cost reductions Brindisi site expected to progressively resume shipments and production during Q3 2024 “FOCUS-27 is leading EUROAPI to a more agile, value-added, and rightsized business model. It will significantly improve the company’s competitiveness and set the stage for long-term sustainable, profitable growth,” says Ludwig de Mot, Chief Executive Officer. “The significant progress made toward its financing is a key milestone....

Second facility opening in 2027 will support family farmers, create new jobs and is a critical part of brand’s journey to achieve at least $1 billion in annual net revenue by 2027 AUSTIN, Texas, June 26, 2024 (GLOBE NEWSWIRE) — Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, today has announced plans to expand its resilient supply chain with a second world-class egg washing and packing facility located in Seymour, Indiana. The 72-acre future home of Egg Central Station (ECS) Seymour will build upon key successes from the brand’s first facility in Springfield, Missouri. The new facility will enable Vital Farms to continue growing its pasture-raised egg business, create 150+ jobs for the Seymour community in its first phase, and is expected to help generate over $350...

Nasdaq CopenhagenLondon Stock Exchange        Euronext DublinOther stakeholders Date     26 June 2024 Ringkjøbing Landbobank issues tier 2 capital Ringkjøbing Landbobank issues tier 2 capital for a total amount of DKK 500 million with effect from 31 July 2024. The capital issue has a maturity of 10.5 years with a first call (redemption) option after 5.5 years. The interest for the entire term to maturity is agreed at a 3-month Cibor rate plus a margin of 200 basis points and with fixing of interest every three months. The issue, which is unlisted, will be made as a private placement with an institutional investor. The issue is part of the bank’s ongoing capital planning. Yours faithfully Ringkjøbing Landbobank John FiskerCEO Attachment EN Tier 2 kapital 26.06.2024

HOUSTON, June 26, 2024 (GLOBE NEWSWIRE) — Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is thrilled to introduce the groundbreaking strategies formulated by its freshly appointed Treasurer and Director, Mr. John Jones, who has facilitated a series of insightful discussions and established official communications between CBIH and a pioneering company in innovative product and packaging solutions for globally recognized brands. As CBIH prepares for the manufacturing and distribution of its products, the potential collaboration might involve this entity acting as CBIH’s product distributor, utilizing its expertise across various sectors such as retail, industrial packaging, manufacturing, production management, product marketing, fulfillment services, design services, and inventory management. Our research and product...

Bagsværd, Denmark, 26 June 2024 – Novo Nordisk today announced that the CLARION-CKD phase 3 trial failed to meet its primary endpoint and that it will recognise an impairment loss of around DKK 5.7 billion related to the intangible asset ocedurenone in the second quarter of 2024. Novo Nordisk acquired ocedurenone from KBP Biosciences PTE., Ltd. in 2023. The phase 3 lead indication trial CLARION-CKD, which investigated ocedurenone in patients with uncontrolled hypertension and advanced chronic kidney disease, was conducted by KBP Biosciences. The trial design included a prespecified interim analysis after all trial participants had completed 12 weeks of treatment. Based on the interim analysis, an independent data monitoring committee concluded that the trial met the prespecified futility criteria – meaning that the trial did not...

Company announcementfor ROCKWOOL A/SRelease no. 36 – 2024to Nasdaq Copenhagen         26 June 2024 New employee-elected Board member in ROCKWOOL A/S Today a by-election has been held for a Group-elected employee representative of the Board of Directors in ROCKWOOL A/S. The employees of ROCKWOOL have chosen that Janni Munkholm Nielsen shall represent them for the remaining election period until the Annual General Meeting in 2026, where new elections for employee-elected Board members will take place. Janni Munkholm Nielsen now joins, Connie Enghus Theisen and Christian Westerberg, as employee-elected Board members in ROCKWOOL A/S. Further information:         Kim Junge AndersenSenior Vice President, CFOROCKWOOL A/S+45 46 55 80 15 Attachment SE-2024-36_EN